Dilating Vascular Diseases: Pathophysiology and Clinical Aspects

Ertan Yetkin1, Selcuk Ozturk2

  • 1Private Yenisehir Hospital, Department of Cardiology, Mersin, Turkey.

Insights

Vessel dilation diseases, including varicose veins and aneurysms, are distinct from atherosclerosis but share similarities. These conditions suggest a systemic vessel wall disease requiring comprehensive patient evaluation.

Area of Science:

  • Vascular Medicine
  • Cardiovascular Pathology

Background:

  • Atherosclerotic disease significantly impacts global mortality and morbidity.
  • Vessel dilation, encompassing venous (varicocele, varicose veins, hemorrhoids) and arterial (aneurysms) conditions, represents a distinct vascular pathology.
  • These dilating vascular diseases are often misclassified as variants of atherosclerosis despite distinct characteristics.

Purpose of the Study:

  • To differentiate dilating vascular diseases from atherosclerosis.
  • To highlight the pathophysiological and histological similarities between arterial and venous dilating diseases.
  • To propose a systemic view of vessel wall disease.

Main Methods:

  • Review of existing literature on atherosclerotic and dilating vascular diseases.
  • Comparative analysis of pathogenesis, histology, and clinical presentation.
  • Synthesis of evidence supporting a systemic vessel wall disease model.

Main Results:

  • Dilating vascular diseases share pathophysiological and histological similarities with each other.
  • Clinical coexistence of these arterial and venous diseases is frequently observed.
  • Despite similarities, dilating vascular diseases are distinct from atherosclerosis.

Conclusions:

  • Dilating vascular diseases should be considered a systemic vessel wall disease, not merely local afflictions.
  • Patients with any dilating vascular disease require systematic evaluation for other related conditions.
  • Recognizing these conditions as systemic enhances patient management and prognosis.

Related Concept Videos

Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
471
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
437
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology01:29

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
1.7K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
435
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.5K